Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 43
Summary
- Conditions
- Breast Cancer
- Breast Cancer - Female
- Breast Cancer - Male
- HER2 Positive Breast Cancer
- Type
- Interventional
- Phase
- Phase 1Phase 2
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03112590
- Collaborators
- Horizon Pharma Ireland, Ltd., Dublin Ireland
- Investigators
- Principal Investigator: (Hyo) Heather S. Han, M.D. H. Lee Moffitt Cancer Center and Research Institute